No, it does not. It provides guidance on remimbursment for approved drugs.
Following Chris L and other long pumpers can be harmful to your financial health.
Further, everybody knows it will be postponed/suspended/canceled because it comes AFTER the approval:
For medicinal products, NICE aims to hold the first appraisal committee meeting as soon as possible after the technology gains a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency, or equivalent from the Medicines and Healthcare products Regulatory Agency. It is therefore essential that the company informs NICE of all developments in the regulatory approval process. This ensures that NICE publishes guidance on the use of the new technology as soon as possible after the company receives the marketing authorisation and introduces the technology in the UK.
Market Data 
Markets 
AI
